77000-1 77000-2
TIM-3 (Mouse), Fc-Fusion (Human)-Avi-Tag, Biotin-Labeled HiP™ Recombinant
BPS Bioscience
DESCRIPTION
Mouse TIM-3, also known as T-cell immunoglobulin mucin receptor 3, T-cell membrane protein 3, TIMD-3, Hepatitis A virus cellular receptor 2, HAVCR-2, and KIM-3. GenBank Accession No. NM_032782, a.a. 22-191, expressed in a HEK293 cells expression system. This protein is fused at the C-terminus to the Fc region of human IgG1 and is enzymatically biotinylated using Avi-tag™ technology. MW = 47 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation.
DETAILS
- Aa: 22-191
- Mw: 47 kDa
- Tags: C-terminal Fc-Avi-Tag, Biotin-Labeled
- Notes: HiP™ indicates a high purity protein with ≥90% purity as measured by gel filtration.
- Format: Aqueous buffer solution.
- Genbank: NM_032782
- Species: Mouse
- Shiptemp: -80°C (dry ice)
- Synonyms: T-cell immunoglobulin mucin receptor 3, T-cell membrane protein 3, TIMD-3, Hepatitis A virus cellular receptor 2, HAVCR-2, KIM-3
- Warnings: Avoid freeze/thaw cycles. Protein may be diluted to ≥100 µg/ml in PBS + glycerol and stored at -80°C.
- Category: Immunotherapy/Protein
- References: 1. Zhu, C. et al., Nat. Immunol. 2005; 6:1245-12525. 2. Anderson, A.C. et al., Science. 2007; 318(5853):1141-1143.
- Description: Mouse TIM-3, also known as T-cell immunoglobulin mucin receptor 3, T-cell membrane protein 3, TIMD-3, Hepatitis A virus cellular receptor 2, HAVCR-2, and KIM-3. GenBank Accession No. NM_032782, a.a. 22-191, expressed in a HEK293 cells expression system. This protein is fused at the C-terminus to the Fc region of human IgG1 and is enzymatically biotinylated using Avi-tag™ technology. MW = 47 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation.
- Formulation: 8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol.
- Unspsc Code: 12352202
- Unspsc Name: Proteins
- Product Type: Protein
- Biosafety Level: Not applicable (BSL-1)
- Related Products: 79096, 79572, 79512
- Storage Stability: At least 6 months at -80°C.
- Scientific Category: Immunotherapy